S&P 500   4,641.91 (-0.29%)
DOW   34,921.10 (-0.61%)
QQQ   399.28 (-0.10%)
AAPL   161.87 (+1.02%)
MSFT   335.25 (-0.41%)
FB   334.40 (-1.07%)
GOOGL   2,909.35 (-0.04%)
AMZN   3,564.42 (+0.08%)
TSLA   1,161.92 (+2.19%)
NVDA   330.48 (-0.98%)
BABA   130.66 (-0.72%)
NIO   41.21 (+1.85%)
CGC   10.98 (-0.72%)
AMD   162.82 (+0.56%)
GE   96.05 (-2.39%)
MU   86.17 (+0.03%)
T   23.11 (-3.26%)
F   19.53 (-0.71%)
DIS   146.27 (-1.04%)
ACB   6.50 (+0.93%)
AMC   36.06 (-2.12%)
PFE   53.58 (+2.25%)
BA   195.94 (-1.29%)
S&P 500   4,641.91 (-0.29%)
DOW   34,921.10 (-0.61%)
QQQ   399.28 (-0.10%)
AAPL   161.87 (+1.02%)
MSFT   335.25 (-0.41%)
FB   334.40 (-1.07%)
GOOGL   2,909.35 (-0.04%)
AMZN   3,564.42 (+0.08%)
TSLA   1,161.92 (+2.19%)
NVDA   330.48 (-0.98%)
BABA   130.66 (-0.72%)
NIO   41.21 (+1.85%)
CGC   10.98 (-0.72%)
AMD   162.82 (+0.56%)
GE   96.05 (-2.39%)
MU   86.17 (+0.03%)
T   23.11 (-3.26%)
F   19.53 (-0.71%)
DIS   146.27 (-1.04%)
ACB   6.50 (+0.93%)
AMC   36.06 (-2.12%)
PFE   53.58 (+2.25%)
BA   195.94 (-1.29%)
S&P 500   4,641.91 (-0.29%)
DOW   34,921.10 (-0.61%)
QQQ   399.28 (-0.10%)
AAPL   161.87 (+1.02%)
MSFT   335.25 (-0.41%)
FB   334.40 (-1.07%)
GOOGL   2,909.35 (-0.04%)
AMZN   3,564.42 (+0.08%)
TSLA   1,161.92 (+2.19%)
NVDA   330.48 (-0.98%)
BABA   130.66 (-0.72%)
NIO   41.21 (+1.85%)
CGC   10.98 (-0.72%)
AMD   162.82 (+0.56%)
GE   96.05 (-2.39%)
MU   86.17 (+0.03%)
T   23.11 (-3.26%)
F   19.53 (-0.71%)
DIS   146.27 (-1.04%)
ACB   6.50 (+0.93%)
AMC   36.06 (-2.12%)
PFE   53.58 (+2.25%)
BA   195.94 (-1.29%)
S&P 500   4,641.91 (-0.29%)
DOW   34,921.10 (-0.61%)
QQQ   399.28 (-0.10%)
AAPL   161.87 (+1.02%)
MSFT   335.25 (-0.41%)
FB   334.40 (-1.07%)
GOOGL   2,909.35 (-0.04%)
AMZN   3,564.42 (+0.08%)
TSLA   1,161.92 (+2.19%)
NVDA   330.48 (-0.98%)
BABA   130.66 (-0.72%)
NIO   41.21 (+1.85%)
CGC   10.98 (-0.72%)
AMD   162.82 (+0.56%)
GE   96.05 (-2.39%)
MU   86.17 (+0.03%)
T   23.11 (-3.26%)
F   19.53 (-0.71%)
DIS   146.27 (-1.04%)
ACB   6.50 (+0.93%)
AMC   36.06 (-2.12%)
PFE   53.58 (+2.25%)
BA   195.94 (-1.29%)
NASDAQ:BFRA

Biofrontera News Headlines

$4.20
-0.08 (-1.87%)
(As of 11/30/2021 09:36 AM ET)
Add
Compare
Today's Range
$4.20
$4.20
50-Day Range
$3.70
$5.90
52-Week Range
$3.70
$9.87
Volume
450 shs
Average Volume
50,410 shs
Market Capitalization
$119.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.1

Media Mentions By Week



Biofrontera Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BFRA
News Sentiment

-0.02

0.27

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BFRA Articles
This Week

24

2

BFRA Articles
Average Week

Get Biofrontera News Delivered to You Automatically

Sign up to receive the latest news and ratings for BFRA and its competitors with MarketBeat's FREE daily newsletter.

Biofrontera (NASDAQ:BFRA) News Headlines Today

SourceHeadline
streetinsider.com logoBiofrontera Inc. (BFRI) Prices $15 Million Private Placement of Common Stock, Warrants - StreetInsider.com
streetinsider.com - November 30 at 10:02 AM
finance.yahoo.com logoBiofrontera Inc. Pricing of $15 Million Private Placement Priced At-the-Market Under Nasdaq Rules - Yahoo Finance
finance.yahoo.com - November 30 at 10:02 AM
marketwatch.com logoBiofrontera Shares Drop 15% After Private Placement Prices - MarketWatch
marketwatch.com - November 29 at 6:35 PM
globenewswire.com logoBiofrontera Inc. Pricing of $15 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
globenewswire.com - November 29 at 1:35 PM
seekingalpha.com logoBiofrontera, Palatin surge amid social media chatter - Seeking Alpha
seekingalpha.com - November 29 at 8:34 AM
marketwatch.com logoBiofrontera Inc. Gains Another 51% - MarketWatch
marketwatch.com - November 28 at 7:40 PM
MarketBeat logoBiofrontera AG (NASDAQ:BFRA) Sees Significant Growth in Short Interest
americanbankingnews.com - November 27 at 10:34 AM
benzinga.com logo48 Stocks Moving In Friday's Mid-Day Session - Benzinga - Benzinga
benzinga.com - November 26 at 5:14 PM
seekingalpha.com logoiSpecimen, Allied Healthcare Products leads healthcare gainers; Longeveron, IM Cannabis among major losers - Seeking Alpha
seekingalpha.com - November 26 at 12:13 PM
benzinga.com logoMid-Morning Market Update: Markets Open Lower; Europe's Regulator Backs Pfizer's COVID-19 Vaccine For Kids Aged 5-11 Years - Benzinga
benzinga.com - November 26 at 12:13 PM
seekingalpha.com logoBiofrontera continues multi-day run as shares up 36% - Seeking Alpha
seekingalpha.com - November 26 at 12:13 PM
benzinga.com logoGlobal Light Activated Therapies Market 2021-2030: Over 635 Patents have been Filed/Granted in Past 3 Yea - Benzinga
benzinga.com - November 26 at 7:12 AM
benzinga.com logo68 Biggest Movers From Wednesday - Benzinga
benzinga.com - November 26 at 7:12 AM
finance.yahoo.com logoBiofrontera Initiated with a Buy at Roth Capital, Stock Surges - Yahoo Finance
finance.yahoo.com - November 25 at 4:07 PM
benzinga.com logoMid-Afternoon Market Update: Dow Falls 75 Points; Biofrontera Shares Spike Higher - Benzinga
benzinga.com - November 24 at 10:46 PM
reuters.com logoHP Inc, Gap Inc, Nordstrom, Qualcomm - Reuters
reuters.com - November 24 at 12:45 PM
benzinga.com logoMid-Day Market Update: Gap Drops Following Downbeat Q3 Results; Ocuphire Pharma Shares Jump - Benzinga
benzinga.com - November 24 at 12:45 PM
investorplace.com logoBENE Stock: 9 Things to Know About DWAC Sister SPAC Benessere Capital - Investorplace.com
investorplace.com - November 24 at 12:45 PM
investorplace.com logoBFRI Stock: 7 Things to Know About Biofrontera as Shares Rocket on $20 Price Prediction - Investorplace.com
investorplace.com - November 24 at 12:45 PM
investorplace.com logoBFRI Stock: 7 Things to Know About Biofrontera as Shares Rocket on $20 Price Prediction
investorplace.com - November 24 at 11:01 AM
globenewswire.com logoBiofrontera Inc. to Report Third Quarter Financial Results - GlobeNewswire
globenewswire.com - November 23 at 10:38 AM
benzinga.com logoThe Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week - Benzinga
benzinga.com - November 22 at 12:39 AM
finance.yahoo.com logoGlobal Light Activated Therapies Market 2021-2030: Focus on Photodynamic Therapies, Photoimmunotherapies and Photothermal Therapies - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - November 19 at 2:52 PM
businesswire.com logoGlobal Light Activated Therapies Market 2021-2030: Focus on Photodynamic Therapies, Photoimmunotherapies and Photothermal Therapies - ResearchAndMarkets.com - Business Wire
businesswire.com - November 19 at 9:51 AM
globenewswire.com logoBiofrontera AG announces mediation results - GlobeNewswire
globenewswire.com - November 19 at 9:51 AM
finance.yahoo.com logoBiofrontera AG announces mediation results
finance.yahoo.com - November 19 at 9:51 AM
seekingalpha.com logoBiofrontera AG (BFRA) CEO Hermann Lübbert on Q3 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 18 at 5:33 PM
finance.yahoo.com logoBiofrontera reports financial results for the third quarter and nine months ended September 30, 2021 - Yahoo Finance
finance.yahoo.com - November 18 at 1:29 AM
globenewswire.com logoBiofrontera reports financial results for the third quarter and nine months ended September 30, 2021 - GlobeNewswire
globenewswire.com - November 17 at 8:29 PM
finance.yahoo.com logoBiofrontera reports financial results for the third quarter and nine months ended September 30, 2021
finance.yahoo.com - November 17 at 8:29 PM
finance.yahoo.com logoBiofrontera AG announces initiation of clinical studies
finance.yahoo.com - November 16 at 12:24 PM
MarketBeat logoBiofrontera AG (NASDAQ:BFRA) Sees Significant Decrease in Short Interest
americanbankingnews.com - November 15 at 11:39 AM
finance.yahoo.com logoLight Activated Therapies Market: Focus on Photodynamic Therapies, Photoimmunotherapies and Photothermal Therapies - Distribution by Target Indications, Key Players and Geographies : Industry Trends and Global Forecasts, 2021-2030 - Yahoo Finance Australia
finance.yahoo.com - November 11 at 7:49 AM
MarketBeat logoBiofrontera (BFRA) Set to Announce Earnings on Wednesday
americanbankingnews.com - November 10 at 9:47 AM
MarketBeat logoAVEO Pharmaceuticals (NASDAQ:AVEO) vs. Biofrontera (NASDAQ:BFRA) Head-To-Head Comparison
americanbankingnews.com - November 10 at 1:12 AM
finance.yahoo.com logoBiofrontera AG: Conference call to discuss third quarter 2021 financial results to be held on November 18, 2021
finance.yahoo.com - November 9 at 8:28 AM
streetinsider.com logoForm 8-K Biofrontera Inc. For: Nov 03 - StreetInsider.com
streetinsider.com - November 3 at 9:11 AM
finance.yahoo.com logoASSYSTEM: Revenue for the nine months ended 30 September 2021 and 2022 financial calendar - Yahoo Finance
finance.yahoo.com - October 29 at 9:23 PM
seekingalpha.com logoBiofrontera orices $18M IPO; trading starts today - Seeking Alpha
seekingalpha.com - October 29 at 9:23 PM
streetinsider.com logoForm 3 Biofrontera Inc. For: Oct 28 Filed by: Monaco Erica L. - StreetInsider.com
streetinsider.com - October 29 at 4:23 PM
streetinsider.com logoBiofrontera Inc. (BFRI) Prices 3.6M Unit IPO at $5/unit - StreetInsider.com
streetinsider.com - October 29 at 8:56 AM
globenewswire.com logoBiofrontera Inc. Announces Pricing of $18.0 Million Initial Public Offering - GlobeNewswire
globenewswire.com - October 29 at 1:32 AM
nasdaq.com logoHealth Care Sector Update for 10/22/2021: ME,BFRA,OCUL,MTCR - Nasdaq
nasdaq.com - October 22 at 7:40 PM
benzinga.com logoBiofrontera Reports Received FDA Approval Of BF-RhodoLED XL Lamp - Benzinga
benzinga.com - October 22 at 2:39 PM
globenewswire.com logoBiofrontera AG receives FDA-approval of the BF-RhodoLED® XL lamp - GlobeNewswire
globenewswire.com - October 22 at 2:39 PM
finance.yahoo.com logoBiofrontera AG receives FDA-approval of the BF-RhodoLED® XL lamp
finance.yahoo.com - October 22 at 2:39 PM
businesswire.com logoGlobal Actinic Keratosis Drugs Market 2021-2025 - Market is Poised to Grow by $709.82 Million - ResearchAndMarkets.com - Business Wire
businesswire.com - October 21 at 2:16 PM
nasdaq.com logoWill Biofrontera (NASDAQ:BFRI) Spend Its Cash Wisely? - Nasdaq
nasdaq.com - October 14 at 10:24 AM
seekingalpha.com logoIPO Update: Biofrontera Pursues $36 Million IPO (Pending:BFRI) - Seeking Alpha
seekingalpha.com - October 1 at 8:30 PM
marketwatch.com logoBiofrontera U.S. Unit Sets IPO at 3 Million Shares; Sees Pricing at $5-$7 - MarketWatch
marketwatch.com - October 1 at 3:23 PM
Get Biofrontera News Delivered to You Automatically

Sign up to receive the latest news and ratings for BFRA and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.